Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis.

J de Seze1, C Lebrun, T Stojkovic

  • 1Department of Neurology, Hôpital R. Salengro, University of Lille, France. j-deseze@chru-lille.fr

Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 30, 2003
PubMed
Summary

Neuromyelitis optica (NMO) and multiple sclerosis (MS) are distinct neurological conditions. Diagnostic criteria, particularly MRI findings, effectively differentiate NMO from MS, suggesting different therapeutic approaches.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Criteria for the use of plasmapheresesis in optic neuritis: A practice review from French expert centers.

Revue neurologique·2025
Same author

Teriflunomide, cognition and MRI: A longitudinal study.

Multiple sclerosis and related disorders·2024
Same author

Clinical applications of deep learning in neuroinflammatory diseases: A scoping review.

Revue neurologique·2024
Same author

A decade of fingolimod in multiple sclerosis: Insights from a large real-world cohort study.

Revue neurologique·2023
Same author

Reverse Takotsubo cardiomyopathy as a complication of MOG-antibody-associated disease (MOGAD)? A case report.

Revue neurologique·2022

Area of Science:

  • Neurology
  • Immunology
  • Neuroinflammation

Background:

  • Devic's neuromyelitis optica (NMO) and multiple sclerosis (MS) share overlapping symptoms like optic neuritis and myelopathy.
  • Distinguishing NMO from MS is crucial as they may represent separate disease entities.
  • Previous studies have not definitively compared these two conditions to establish their relationship.

Purpose of the Study:

  • To compare clinical and laboratory findings in patients with NMO and MS.
  • To determine if NMO is a distinct entity or a subtype of MS.
  • To evaluate the diagnostic utility of MRI and CSF findings in differentiating NMO and MS.

Main Methods:

  • Retrospective study of 30 NMO patients and 50 MS patients presenting with optic neuritis or myelopathy.

Related Experiment Videos

  • Comparison of clinical presentation, cerebrospinal fluid (CSF) analysis (oligoclonal bands), and magnetic resonance imaging (MRI) findings.
  • Evaluation of clinical outcomes and disease dissemination (time and space).

    • Main Results:

    • NMO patients were older and more frequently female than MS patients, though not significantly.
    • CSF and MRI data showed significant differences: oligoclonal bands (23% NMO vs. 88% MS), abnormal brain MRI (10% NMO vs. 66% MS), and large spinal cord lesions (67% NMO vs. 7.4% MS).
    • Clinical outcomes were more severe in the NMO group (P < 0.001).

    Conclusions:

    • Neuromyelitis optica (NMO) and multiple sclerosis (MS) are distinct neurological entities.
    • MRI parameters are critical in differentiating NMO from MS.
    • These findings have implications for future therapeutic strategies and clinical trial design.